Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Clinical trial NCT04756726 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04756726
- Sponsor
- C4 Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2026-09-30
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.